155 related articles for article (PubMed ID: 12574873)
1. Urinary cross-linked N-telopeptides of type I collagen levels in patients with rheumatoid arthritis.
Iwamoto J; Takeda T; Ichimura S
Calcif Tissue Int; 2003 Apr; 72(4):491-7. PubMed ID: 12574873
[TBL] [Abstract][Full Text] [Related]
2. Urine levels of type 1 collagen cross-linked N-telopeptides and deoxypyridinoline correlate with disease activity in rheumatoid arthritis.
al-Awadhi AM; Olusi SO; al-Zaid NS; Prabha K; al-Jarallah KH; Ahmed AH; al-Salem I; Sedeqi H; Atteyah Y
Clin Exp Rheumatol; 1998; 16(5):569-72. PubMed ID: 9779304
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of type I collagen crosslinked N-telopeptides in healthy Japanese adults: age- and sex-related changes and reference limits.
Sone T; Miyake M; Takeda N; Fukunaga M
Bone; 1995 Oct; 17(4):335-9. PubMed ID: 8573404
[TBL] [Abstract][Full Text] [Related]
4. Specific changes of urinary excretion of cross-linked N-telopeptides of type I collagen in pre- and postmenopausal women: correlation with other markers of bone turnover.
Gorai I; Taguchi Y; Chaki O; Nakayama M; Minaguchi H
Calcif Tissue Int; 1997 Apr; 60(4):317-22. PubMed ID: 9075625
[TBL] [Abstract][Full Text] [Related]
5. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K
J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
[TBL] [Abstract][Full Text] [Related]
6. The effect of methotrexate on bone metabolism markers in patients with rheumatoid arthritis.
Torikai E; Kageyama Y; Takahashi M; Nagano A
Mod Rheumatol; 2006; 16(6):350-4. PubMed ID: 17164995
[TBL] [Abstract][Full Text] [Related]
7. Forearm bone mineral density in patients with rheumatoid arthritis.
Iwamoto J; Takeda T; Ichimura S
J Orthop Sci; 2002; 7(5):528-34. PubMed ID: 12355125
[TBL] [Abstract][Full Text] [Related]
8. Change of cross-linked telopeptide of type I collagen (ICTP) and other bone resorption markers in patients with bone fragility fractures.
Takahara K; Kamimura M; Hashidate H; Uchiyama S; Nakagawa H
J Orthop Sci; 2007 May; 12(3):219-26. PubMed ID: 17530373
[TBL] [Abstract][Full Text] [Related]
9. Effects of age, menopause and osteoporosis on free, peptide-bound and total pyridinium crosslink excretion.
Del Campo MT; González-Casaus ML; Aguado P; Bernad M; Carrera F; Martínez ME
Osteoporos Int; 1999; 9(5):449-54. PubMed ID: 10550465
[TBL] [Abstract][Full Text] [Related]
10. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
Charni N; Juillet F; Garnero P
Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
[TBL] [Abstract][Full Text] [Related]
11. Differences in bone resorption after menopause in Japanese women with normal or low bone mineral density: quantitation of urinary cross-linked N-telopeptides.
Taguchi Y; Gorai I; Zhang MG; Chaki O; Nakayama M; Minaguchi H
Calcif Tissue Int; 1998 May; 62(5):395-9. PubMed ID: 9541516
[TBL] [Abstract][Full Text] [Related]
12. Serum osteocalcin levels in premenopausal rheumatoid arthritis patients.
Seriolo B; Ferretti V; Sulli A; Caratto E; Fasciolo D; Cutolo M
Ann N Y Acad Sci; 2002 Jun; 966():502-7. PubMed ID: 12114311
[TBL] [Abstract][Full Text] [Related]
13. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.
Chaki O; Yoshikata I; Kikuchi R; Nakayama M; Uchiyama Y; Hirahara F; Gorai I
J Bone Miner Res; 2000 Aug; 15(8):1537-44. PubMed ID: 10934652
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion of type I collagen cross-linked N-telopeptides, bone mass and related lifestyle in middle-aged women.
Masatomi C; Imai K; Wang DH; Ikeda S; Taketa K; Takata S; Kira S
Acta Med Okayama; 1999 Jun; 53(3):133-40. PubMed ID: 10410791
[TBL] [Abstract][Full Text] [Related]
15. Correlation of urine type I collagen-cross-linked N telopeptide levels with bone scintigraphic results in prostate cancer patients.
Fukumitsu N; Uchiyama M; Mori Y; Yanada S; Hatano T; Igarashi H; Kishimoto K; Nakada J; Yoshihiro A; Harada J
Metabolism; 2002 Jul; 51(7):814-8. PubMed ID: 12077723
[TBL] [Abstract][Full Text] [Related]
16. The effects of sulphasalazine on urinary excretion of the hydroxypyridinium crosslinks of collagen in patients with rheumatoid arthritis.
Dílek K; Alí I; Göksal K; Hüseyin T; Güner T
Yonsei Med J; 2002 Aug; 43(4):435-40. PubMed ID: 12205730
[TBL] [Abstract][Full Text] [Related]
17. Spot urine concentrations of type I collagen cross-linked N-telopeptides and deoxypyridinoline in psoriatic arthritis.
Al-Awadhi AM; Olusi SO; Al-Zaid NS; George S; Sugathan TN
Clin Rheumatol; 1999; 18(6):450-4. PubMed ID: 10638769
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of bone-turnover metabolites in the diagnosis of bone metastases in patients with lung carcinoma.
Izumi M; Nakanishi Y; Takayama K; Kimotsuki K; Inoue K; Wataya H; Minami T; Hara N
Cancer; 2001 Apr; 91(8):1487-93. PubMed ID: 11301396
[TBL] [Abstract][Full Text] [Related]
19. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
[TBL] [Abstract][Full Text] [Related]
20. Relationship between bone mineral density and urine level of NTx in rheumatoid arthritis.
Nonaka T; Nishisaka F; Fukuda K; Sohen S; Hamanishi C
J Bone Miner Metab; 2005; 23(4):314-7. PubMed ID: 15981028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
